Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox (CLX) to $139 from $140 and keeps an Underweight rating on the shares. Ahead of Q1 earnings, the firm revisited estimates across beverages and consumer products to account for slower consumer demand in the U.S. among other headwinds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $169 from $171 at DA Davidson
- Clorox price target raised to $140 from $130 at Barclays
- Clorox Charts Growth Path Amid Positive Earnings Call
- Clorox’s Mixed Performance Leads to Hold Rating Amid Competitive Pressures and Market Challenges
- CLX Earnings: Clorox Raises Guidance after Surpassing Quarterly Expectations